COMMUNIQUÉS West-GlobeNewswire

Noom Unveils New Diabetes Lifestyle Program and Predictive Glucose Forecasting to Tackle America’s Diabetes Crisis
06/11/2025
Innovative tools give employers, health plans, and individuals proactive ways to prevent and manage diabetes—one of the nation’s fastest-growing and most costly chronic conditions PRINCETON, N.J., Nov. 06, 2025 (GLOBE [...]
Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results
06/11/2025
Held meeting with U.S. Food and Drug Administration (FDA) where, among other things, they reiterated October 2024 agreement to use estimated glomerular filtration rate (eGFR) slope as an endpoint to support accelerated [...]
STRATA Skin Sciences Announces CMS Recognition of Expanded CPT Codes for Inflammatory and Autoimmune Dermatologic Conditions with Company Anticipating Wider Excimer Adoption Ahead Of 2027 CPT Expansion
06/11/2025
Higher reimbursement, regulatory clarity, and acknowledgment of future indication expansion expected to reinforce physician confidence and support continued expansion HORSHAM, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- [...]
Solid Biosciences Awarded Innovation Passport Designation Under the New UK Innovative Licensing and Access Pathway for SGT-003, an Investigational Gene Therapy for Duchenne Muscular Dystrophy
06/11/2025
- Innovation Passport award facilitates accelerated time to market and helps expedite patient access to transformative new medicines - - New Innovative Licensing and Access Pathway (ILAP) designation provides unique, [...]
Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis
06/11/2025
— Phase 2 SPRING Trial Open Label Extension Showed Favorable Safety and Consistent Improvements in Key Biomarkers in PSC Patients Treated with Nebokitug for Up to 48 Weeks— —New Clinical Data Provides Insights on [...]
Dentsply Sirona Reports Third Quarter 2025 Results
06/11/2025
Dentsply Sirona Reports Third Quarter 2025 Results Net sales of $904 million decreased (5.0%) as-reported, decreased (8.0%) in constant currency including (5.5%) driven by Q3 2024 Byte impact and ERP pre-buy GAAP gross [...]
Humacyte to Present Third Quarter Financial Results and Provide Business Update on November 12, 2025
06/11/2025
DURHAM, N.C., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, will [...]
Daré Bioscience to Host Third Quarter 2025 Financial Results and Company Update Conference Call and Webcast on November 13, 2025
06/11/2025
SAN DIEGO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real [...]
PDS Biotech Announces Conference Call and Webcast for Third Quarter 2025 Financial Results
06/11/2025
PRINCETON, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets [...]
Healthcare Minus the Headache: RokketMed, A Solution to Finding the Care That Counts
06/11/2025
Turnkey San Francisco Platform Aims to Help All Employers and Workers SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- In the face of mounting healthcare compliance complexity and an urgent need for accessible [...]
Raise Craze, a partnership between the MUHC Foundation, The Beat 92.5, and Pink in the City, raised $162,160 for breast cancer care at the MUHC
06/11/2025
MONTREAL, Nov. 06, 2025 (GLOBE NEWSWIRE) -- During October’s Breast Cancer Awareness Month, the MUHC Foundation once again partnered with The Beat 92.5 and Pink in the City, raising an extraordinary $162,160 for breast [...]
La campagne Raise Craze, un partenariat entre la Fondation du CUSM, The Beat 92.5 et Pink in the City, recueille 162,160 $ pour les soins contre le cancer du sein au CUSM
06/11/2025
MONTRÉAL, 06 nov. 2025 (GLOBE NEWSWIRE) -- Dans le cadre du Mois de la sensibilisation au cancer du sein en octobre, la Fondation du CUSM s’est de nouveau associée à The Beat 92.5 et Pink in the City. La campagne a [...]
Vera Therapeutics Announces Positive ORIGIN Phase 3 Data for Atacicept in IgA Nephropathy Presented at ASN Kidney Week 2025 and Published in the New England Journal of Medicine
06/11/2025
Atacicept met the primary endpoint of reduction in proteinuria (UPCR) at week 36; participants receiving atacicept achieved a 46% reduction from baseline and 42% reduction compared to placebo at week 36 (p<0.0001) [...]
Porch Light Health Launches Advanced Drug Lab to Improve Patient Safety and Spot Dangerous Drug Trends in Our Communities
06/11/2025
FORT COLLINS, Colo., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Porch Light Health, a leading outpatient substance use disorder treatment provider serving Colorado and New Mexico, announces the opening of its new drug toxicology [...]
Pennant Group to Participate in the 2025 Stephens Annual Investment Conference
06/11/2025
EAGLE, Idaho, Nov. 06, 2025 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
PharmaCorp Announces Upsized C$20 Million Bought Deal Public Offering
06/11/2025
The Base Shelf Prospectus is accessible, and the Prospectus Supplement will be accessible, through SEDAR+ NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES SASKATOON, [...]
Ernexa Therapeutics Showcases Strategic Partnership with Cellipont Bioservices to Advance Toward First-in-Human Trials on Virtual Investor “What This Means” Platform
06/11/2025
Access the “What This Means” segment here CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced [...]
Alvotech and Advanz Pharma Receive Marketing Authorisations for Gobivaz®, a Biosimilar to Simponi® (golimumab), from the MHRA
06/11/2025
REYKJAVIK, Iceland and LONDON, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and [...]
Consortium consisting of Nordic Capital and Permira announces preliminary result of the takeover offer to shareholders of Bavarian Nordic and that the Offer is withdrawn and will not be completed
06/11/2025
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION COPENHAGEN, Denmark, 6 [...]

Pages